585 participants
BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-07-26
- Start Date:
- 2008-04-30
- Completion:
- 2013-10-31
Conditions
- Carcinoma, Non-Small-Cell Lung
Interventions
- DRUG